183 related articles for article (PubMed ID: 18367100)
1. Are PSA density and PSA density of the transition zone more accurate than PSA in predicting the pathological stage of clinically localized prostate cancer?
Giannarini G; Scott CA; Moro U; Pertoldi B; Beltrami CA; Selli C
Urol Oncol; 2008; 26(4):353-60. PubMed ID: 18367100
[TBL] [Abstract][Full Text] [Related]
2. Prediction of extraprostatic cancer by prostate specific antigen density, endorectal MRI, and biopsy Gleason score in clinically localized prostate cancer.
Horiguchi A; Nakashima J; Horiguchi Y; Nakagawa K; Oya M; Ohigashi T; Marumo K; Murai M
Prostate; 2003 Jun; 56(1):23-9. PubMed ID: 12746843
[TBL] [Abstract][Full Text] [Related]
3. Validation of a nomogram predicting the probability of lymph node invasion based on the extent of pelvic lymphadenectomy in patients with clinically localized prostate cancer.
Briganti A; Chun FK; Salonia A; Gallina A; Farina E; Da Pozzo LF; Rigatti P; Montorsi F; Karakiewicz PI
BJU Int; 2006 Oct; 98(4):788-93. PubMed ID: 16796698
[TBL] [Abstract][Full Text] [Related]
4. An artificial neural network for prostate cancer staging when serum prostate specific antigen is 10 ng./ml. or less.
Zlotta AR; Remzi M; Snow PB; Schulman CC; Marberger M; Djavan B
J Urol; 2003 May; 169(5):1724-8. PubMed ID: 12686818
[TBL] [Abstract][Full Text] [Related]
5. Predicting pathological stage of localized prostate cancer using volume weighted mean nuclear volume.
Fujikawa K; Matsui Y; Kobayashi T; Miura K; Oka H; Fukuzawa S; Takeuchi H
J Urol; 2000 Nov; 164(5):1587-90. PubMed ID: 11025710
[TBL] [Abstract][Full Text] [Related]
6. Is prostate-specific antigen (PSA) density better than the preoperative PSA level in predicting early biochemical recurrence of prostate cancer after radical prostatectomy?
Jones TD; Koch MO; Bunde PJ; Cheng L
BJU Int; 2006 Mar; 97(3):480-4. PubMed ID: 16469012
[TBL] [Abstract][Full Text] [Related]
7. Serum tPSA, cPSA, related density parameters and chromogranin A as predictors of positive margins after radical prostatectomy.
Custovic Z; Kraus O; Tomaskovic I; Tarle M
Anticancer Res; 2007; 27(4C):2817-21. PubMed ID: 17695453
[TBL] [Abstract][Full Text] [Related]
8. Prostate-specific antigen versus prostate-specific antigen density as predictor of tumor volume, margin status, pathologic stage, and biochemical recurrence of prostate cancer.
Brassell SA; Kao TC; Sun L; Moul JW
Urology; 2005 Dec; 66(6):1229-33. PubMed ID: 16360448
[TBL] [Abstract][Full Text] [Related]
9. Prediction of pelvic lymph node metastasis by the ratio of cathepsin B to stefin A in patients with prostate carcinoma.
Sinha AA; Quast BJ; Wilson MJ; Fernandes ET; Reddy PK; Ewing SL; Gleason DF
Cancer; 2002 Jun; 94(12):3141-9. PubMed ID: 12115346
[TBL] [Abstract][Full Text] [Related]
10. Validation of Partin tables for predicting pathological stage of clinically localized prostate cancer.
Blute ML; Bergstralh EJ; Partin AW; Walsh PC; Kattan MW; Scardino PT; Montie JE; Pearson JD; Slezak JM; Zincke H
J Urol; 2000 Nov; 164(5):1591-5. PubMed ID: 11025711
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation for clinical staging parameters of prostate neoplasm].
Zhong CY; Liu M; Zhang LQ; Wan B
Zhonghua Nan Ke Xue; 2003 Apr; 9(2):100-2. PubMed ID: 12749126
[TBL] [Abstract][Full Text] [Related]
12. The outcome of patients with pathological Gleason score >or=8 prostate cancer after radical prostatectomy.
Rodriguez-Covarrubias F; Larre S; De La Taille A; Abbou CC; Salomon L
BJU Int; 2008 Feb; 101(3):305-7. PubMed ID: 17941921
[TBL] [Abstract][Full Text] [Related]
13. Side-specific factors associated with extracapsular extension and seminal vesicular invasion in men undergoing open radical retropubic prostatectomy.
Sankin A; Tareen B; Lepor H
Prostate Cancer Prostatic Dis; 2009; 12(2):204-8. PubMed ID: 19238170
[TBL] [Abstract][Full Text] [Related]
14. Prediction of extraprostatic extension by prostate specific antigen velocity, endorectal MRI, and biopsy Gleason score in clinically localized prostate cancer.
Nishimoto K; Nakashima J; Hashiguchi A; Kikuchi E; Miyajima A; Nakagawa K; Ohigashi T; Oya M; Murai M
Int J Urol; 2008 Jun; 15(6):520-3. PubMed ID: 18422574
[TBL] [Abstract][Full Text] [Related]
15. Laparoscopic pelvic lymph node dissection in the staging of prostate cancer.
Stone NN; Stock RG
Mt Sinai J Med; 1999 Jan; 66(1):26-30. PubMed ID: 9989102
[TBL] [Abstract][Full Text] [Related]
16. [Predicting factors of tumor organ-confinement in adenocarcinoma of the prostate].
Borque Fernando A; Allepuz Losa C; Del Agua Arias C; Valdivia Navarro P; Ascaso Cornago I; Rioja Sanz LA
Actas Urol Esp; 1997 Oct; 21(9):890-7. PubMed ID: 9471872
[TBL] [Abstract][Full Text] [Related]
17. Percentage of positive biopsy cores can improve the ability to predict lymph node invasion in patients undergoing radical prostatectomy and extended pelvic lymph node dissection.
Briganti A; Karakiewicz PI; Chun FK; Gallina A; Salonia A; Zanni G; Valiquette L; Graefen M; Huland H; Rigatti P; Montorsi F
Eur Urol; 2007 Jun; 51(6):1573-81. PubMed ID: 17293026
[TBL] [Abstract][Full Text] [Related]
18. Study of prostate cancer pathologic features in Chinese populations.
Chuang AY; Chang SJ; Horng CF; Tsou MH
Urology; 2007 May; 69(5):915-20. PubMed ID: 17482934
[TBL] [Abstract][Full Text] [Related]
19. Multivariate models as predictors of pathological stage using Gleason score, clinical stage, and serum prostate-specific antigen.
Polascik TJ; Pearson JD; Partin AW
Semin Urol Oncol; 1998 Aug; 16(3):160-71. PubMed ID: 9741421
[TBL] [Abstract][Full Text] [Related]
20. Prostate-specific antigen density predicts adverse pathology and increased risk of biochemical failure.
Radwan MH; Yan Y; Luly JR; Figenshau RS; Brandes SB; Bhayani SB; Bullock AD; Liefu Y; Andriole GL; Kibel AS
Urology; 2007 Jun; 69(6):1121-7. PubMed ID: 17572199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]